PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Short Interest Up ? in April

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) saw a significant growth in short interest in April. As of April 30th, there was short interest totaling 1,224 shares, a growth of ? from the April 15th total of 0 shares. Based on an average daily trading volume, of 43,884 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

PreveCeutical Medical Price Performance

PRVCF stock traded down $0.01 during mid-day trading on Monday, reaching $0.01. 100,000 shares of the stock traded hands, compared to its average volume of 51,291. PreveCeutical Medical has a 52-week low of $0.00 and a 52-week high of $0.04. The stock’s fifty day moving average is $0.01 and its 200-day moving average is $0.02.

PreveCeutical Medical Company Profile

PreveCeutical Medical Inc is a biotechnology company focused on developing non-opioid therapies that target the endocannabinoid system through advanced translational medicine. The company leverages proprietary research in prebiotic and synthetic bioactive compounds to create drug candidates and wellness formulations aimed at addressing metabolic, inflammatory and neurodegenerative disorders. PreveCeutical’s science-driven approach emphasizes collaboration with leading academic institutions to translate laboratory discoveries into therapeutic solutions.

Central to PreveCeutical’s development pipeline is PREV-IX7, a prebiotic drug candidate designed to modulate the gut microbiome for treatment of metabolic syndrome and related endocrine imbalances.